Sphingolipid profiles in plasma and breath condensate differed between IPF and f-HP and tracked with disease severity, CHEST 2026 data show.

New abstracts show the oral PCSK9 inhibitor cut LDL-C by 57% to 63% across PREVENT risk groups, with reductions maintained in an extension study.

In more than 250,000 adults with prediabetes and obesity, GLP-1 users had lower risks of type 2 diabetes, death, and cardiovascular events.

HS is a systemic disease with significant comorbidity, which complicates care. Dr. Lev-Tov argues that published guidelines and clear referral pathways make this burden manageable for dermatologists ...

In nearly 443,000 US adults, both low-frequency and heavy cannabis use were linked to higher odds of cardiovascular disease, led by stroke.

The FDA granted accelerated approval to the first plasmid DNA-based immunotherapy for adults with recurrent respiratory papillomatosis (RRP).

Facing steep 2027 cost increases, employers are narrowing obesity drug coverage, while direct-to-employer models let them cap ...

Patients on tegoprubart reported fewer transplant-related symptoms and better quality of life at 12 months than those on ...

Karin Johnson, MD, says permanent daylight saving time won’t boost exercise or road safety and that sleep loss from spring ...

Nikhil C. Munshi, MD, says 25% to 30% of patients with myeloma may now be cured, but relapse and access remain challenges.

Cleveland Clinic's Beth Faiman, PhD, MSN, says fast-moving myeloma care requires funded education and fewer barriers for ...

Mayo Clinic case-control study links higher birth weight and childhood obesity to greater non-Hodgkin lymphoma risk, while ...